Inside Capitol Hill’s Fight for Diabetes Care: What These Advocates Need You to Know
Diabetes Connections | Type 1 Diabetes
Release Date: 12/09/2025
Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse
Diabetes Connections | Type 1 Diabetes
This week on Diabetes Connections, a conversation about what really matters in diabetes. We’re talking about the top stories of 2025, the hype that didn’t happen, some trends for 2026, what community can accomplish, and what LeBron James has to do with all of this. We also get personal – because I’m being interviewed by the wonderful Neil Greathouse, host of Your Best T1D life, and so much more. This episode contains a replay of This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community...
info_outline
Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes
Diabetes Connections | Type 1 Diabetes
Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...
info_outline
She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes?
Diabetes Connections | Type 1 Diabetes
What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more. Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...
info_outline
Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know
Diabetes Connections | Type 1 Diabetes
It’s been a big month for announcements from Dexcom! What does that mean for you? From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Learn more about ...
info_outline
Inside Capitol Hill’s Fight for Diabetes Care: What These Advocates Need You to Know
Diabetes Connections | Type 1 Diabetes
We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of . We’ve got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you’ve ever thought your voice doesn’t matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outline
In the News... Libre Freestyle recall, Dexcom 15 day launch, Omnipod & Tandem updates, Medicare price adjustments and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by...
info_outline
Preventing Type 1 Diabetes? Dr. Michael Haller on ATG Research (Plus, Afrezza for Kids)
Diabetes Connections | Type 1 Diabetes
We've got a research update on two of the topics you’ve told me you want to hear more about. First, research into Preventing type 1 – with a therapy that hasn’t been in the headlines.. and second, inhaled insulin for kids. We’re talking to , a peds endo who is at the forefront of these studies. We’ll be talking about something called ATG – which looks really good in very low dose trials – and about the latest studies around inhaled insulin for kids – which is in front of the FDA right now. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outline
Rethinking Type 1 Screening with Adam Schefter & Dr. Shara Bialo
Diabetes Connections | Type 1 Diabetes
With lots of family time coming up this week for many of us, it’s a great time to talk about screening for type 1. While this might seem to be a real downer of a Thanksgiving conversation, screening is now considered standard of care for people with a family history of T1D. My guests want to get the word out about that – and they’ve both walked the walk. Adam Schefter is ESPN Senior NFL Insider – his wife lives with type 1.. and Dr. Shara Bialo is a pediatric endo who lives with type 1. This podcast is not intended as medical advice. If you have those kinds of questions, please contact...
info_outline
Diabetes Sports Project: Competing at the highest levels with type 1 diabetes
Diabetes Connections | Type 1 Diabetes
The Diabetes Sprots project says it’s an organization built to inspire. What can we all learn about elite athletes with type 1 – the people running marathons and doing Iron Man competitions. And with the right support and education, how far can those athletes go? We’re talking about the Olympics and more with DSP founder Casey Boren and volunteer Lauren Adams, both of whom live with type 1 (and both of whom had done a ten mile run before we started taping). Learn more about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...
info_outline
In the News... It's World Diabetes Day! Top stories and headlines for Nov 14, 2025
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly...
info_outlineWe're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of DPAC, the Diabetes Patient Advocacy Coalition.
We’ve got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins.
I know some of you are cynical, but it can work. If you’ve ever thought your voice doesn’t matter, this conversation may change your mind.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Announcing Community Commericals! Learn how to get your message on the show here.
Learn more about studies and research at Thrivable here
Please visit our Sponsors & Partners - they help make the show possible!
Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)
Check out VIVI Cap to protect your insulin from extreme temperatures
The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:Sign up for our newsletter here
Here's where to find us:
Learn more about everything at our home page www.diabetes-connections.com
Reach out with questions or comments: info@diabetes-connections.
Keywords
Diabetes, D-PAC, Medicare, GLP-1 medications, patient advocacy, healthcare access, insulin pumps, CGMs, diabetes technology, legislative reform
AI info below:
Summary
In this conversation, George Huntley, CEO of the Diabetes Patient Advocacy Coalition (D-PAC), discusses the critical role of advocacy in improving diabetes care and access to technology. He highlights the challenges faced by patients, particularly regarding Medicare coverage for insulin pumps and continuous glucose monitors (CGMs), and the implications of recent legislative changes. The discussion also covers the potential of GLP-1 medications in diabetes management and the importance of patient stories in advocacy efforts.
Takeaways
D-PAC focuses on affordable and equitable access to diabetes care.
Advocacy is crucial for influencing healthcare policies.
Competitive bidding for diabetes technology could limit access for seniors.
Patient stories are essential in legislative advocacy.
GLP-1 medications show promise in reshaping diabetes treatment.
Economic factors play a significant role in healthcare access.
The aging population of type 1 diabetes patients requires urgent attention.
Collaboration among advocacy groups is vital for success.
Healthcare costs are driven more by major medical expenses than by drug prices.
Continued advocacy is necessary to protect patient access to care.
Chapters
00:00 Introduction to Diabetes Advocacy
03:01 The Role of D-PAC in Diabetes Care
05:53 Challenges in Medicare Coverage for Diabetes Technology
09:11 The Impact of Competitive Bidding on Seniors
11:55 Advocacy Efforts and Legislative Challenges
14:57 The Future of GLP-1 Medications
17:56 Economic Implications of Diabetes Management
21:01 The Importance of Patient Advocacy
23:59 Healthcare Costs and Insurance Dynamics
26:56 The Need for Continued Advocacy
29:54 Conclusion and Call to Action